{"type":"trials","record":{"id":28190,"source_id":"clinicaltrials-gov","external_id":"NCT06118905","title":"Preserving Geriatric Muscle With an Osteoporosis Medication","brief_summary":"Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve muscle health, strength, mobility and function in frail older adults.","overall_status":"Recruiting","phases":["PHASE4"],"study_type":"INTERVENTIONAL","sponsor":"Chrissy Kistler","enrollment":155,"countries":["United States"],"start_date":"2024-02-08","completion_date":"2029-03-31","last_update_date":"2026-09-23","source_url":"https://clinicaltrials.gov/study/NCT06118905","editorial_summary":"A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T00:17:12.269849+00:00","last_seen_at":"2026-09-25T06:20:19.667+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"65 Years","comparator":"Zoledronic acid","organization":"University of Pittsburgh","interventions":["Denosumab 60 MG/ML","Zoledronic Acid 5Mg/Bag 100Ml Infusion"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Knee extension strength change — 12 Months"],"design_description":"RANDOMIZED · PARALLEL · TREATMENT · DOUBLE","source_has_results":false},"controlled_terms":["Osteoporosis","Denosumab 60 MG/ML","Zoledronic Acid 5Mg/Bag 100Ml Infusion"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":100,"publication_state":"published","match_explanation":"Title contains controlled term: osteoporosis.","quality_checked_at":"2026-09-25T06:20:27.00315+00:00","duplicate_cluster_key":"id:nct06118905","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2024-02-08 to 2029-03-31","comparator":"Zoledronic acid","confidence":"structured-source","population":"ALL · 65 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:20:19.667Z","intervention":["Denosumab 60 MG/ML","Zoledronic Acid 5Mg/Bag 100Ml Infusion"],"participants":155,"study_design":"RANDOMIZED · PARALLEL · TREATMENT · DOUBLE","subject_scope":"Human clinical study registration","evidence_stage":"PHASE4","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Knee extension strength change — 12 Months"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"bone-aging","is_published":true,"match_reasons":["Title contains controlled term: osteoporosis.","Source terminology contains: osteoporosis.","Title supplies longevity context: geriatric.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["title","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Bone ageing","slug":"bone-aging"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/28190","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}